Talk Presenting Companies (Theatre B) track
Technologies and Tools: Constellate Proteomics
Tue, Nov 10, 2026 · 2:00–2:15 PM CET Koelnmesse
About this session
Constellate Proteomics enables antibody therapeutic developers to assess the quality of their product as early and often as necessary, with a highly sensitive and versatile analysis platform. Their innovative single-molecule analysis technology allows Constellate devices to automatically analyze a variety of attributes - including titer, glycosylation properties, aggregation and charge variants. This data can be used to efficiently steer drug development processes from day 1, and build sophisticated digital twin models of antibody cell lines.
Speaker
-
CEO · Constellate Proteomics
Speaker